Armstrong’s Primatene Mist Inhaler Has 2011 Deadline To Exit The Market
This article was originally published in The Tan Sheet
Executive Summary
Generics manufacturer Armstrong Pharmaceuticals now has until the end of 2011 to remove Primatene Mist and private-label epinephrine inhalers from the market